HIGH

Zydus Entacavir Recall 600 Bottles Over Impurity Degradation Issue (2025)

Zydus Lifesciences and Zydus Pharmaceuticals USA recall 600 bottles of Entacavir 1 mg tablets distributed nationwide in the United States. An out-of-specification organic impurity triggered the recall. Stop use immediately and contact a healthcare provider or Zydus for guidance.

Quick Facts at a Glance

Recall Date
September 24, 2025
Hazard Level
HIGH
Brands
Entacavir, Zydus Pharmaceuticals USA Inc.
Category
Health & Personal Care
Sold At
Unknown
Geographic Scope
1 states
At-Risk Groups
GENERAL, PREGNANT, PETS

Hazard Information

Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Zydus Pharmaceuticals (USA) Inc or your healthcare provider for guidance. Notification method: Letter

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

Entacavir is an antiviral used to treat hepatitis B infection. It is prescribed by physicians and distributed to patients nationwide.

Why This Is Dangerous

The product failed impurity/degradation specifications, indicating an organic impurity beyond acceptable limits, which could pose safety risks if consumed.

Industry Context

This recall is not indicated as part of a broader industry pattern in the provided data.

Real-World Impact

No incidents reported in the notice, but patients must stop use and consult their clinician to determine next steps.

Practical Guidance

How to identify if yours is affected

  1. Verify lot number E409309 on the bottle
  2. Check expiration date 12/31/2026
  3. Confirm NDC 68382-921-06 on packaging

Where to find product info

Label shows lot number, expiration date, NDC code, and manufacturer information

What timeline to expect

Refunds or replacements processed per company policy after notification; no firm timeline provided

If the manufacturer is unresponsive

  • Escalate with FDA recall portal or consumer protection office
  • Seek guidance from healthcare provider while pursuing replacement

How to prevent similar issues

  • Always verify lot numbers and expiration dates before dispensing medications
  • Report any adverse events to FDA MedWatch
  • Review drug recall notices from FDA for antiviral medications

Documentation advice

Keep recall notice, packaging, receipts, and communication logs with manufacturer for records

Product Details

Model numbers: Lot# E409309. Expiration: 12/31/2026. Quantity: 600 bottles. Sold nationwide in the USA. Manufactured by Zydus Lifesciences Ltd., Ahmedabad, India. Distributed by Zydus Pharmaceuticals USA Inc., Pennington, NJ 08534. NDC 68382-921-06.

Reported Incidents

No consumer injury or adverse event data provided in the recall notice.

Key Facts

  • 600 bottles recalled
  • NDC 68382-921-06
  • Lot E409309
  • Exp 12/31/2026
  • Distributed nationwide in USA
  • High hazard level

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERALPREGNANTPETS
Injury Types
POISONINGOTHER

Product Details

Model Numbers
LotE409309
UPC Codes
68382-920
68382-921
68382-920-06
+9 more
Affected States
ALL
Report Date
October 8, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Vehicles & Parts
HIGH

Mazda CX-70 Recall 2025 for Powertrain Control Module Software May Lose Drive Power

Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.

Mazda
Loss of
Read more
Vehicles & Parts
HIGH

Nissan Kicks 2025 Certification Label Recall for GVWR/GAWR Errors (PD136, PMA47)

Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.

Nissan
An overloaded
Read more